Drug administration through an enteral feeding tube

American Journal of Nursing

Volumn 109, Issue 10, 2009, Pages 34-42

  Boullata, Joseph I ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DIGESTIVE TRACT INTUBATION; DRUG ADMINISTRATION ROUTE; DRUG THERAPY; ENTERIC FEEDING; HUMAN; METHODOLOGY; NURSING; PHARMACOKINETICS; PRACTICE GUIDELINE; UNITED STATES;

DRUG ADMINISTRATION ROUTES; DRUG THERAPY; ENTERAL NUTRITION; HUMANS; INTUBATION, GASTROINTESTINAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 70349690625     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.NAJ.0000361488.45094.28     Document Type: Article

References (50)

1. de Vries EN, et al. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care 2008;17(3):216-223
2. Kohn LT, et al., editors. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.
3. Beckwith MC, et al. A guide to drug therapy in patients with enteral feeding tubes: dosage form selection and administration methods. Hosp Pharm 2004;39(3):225-237
4. Dickerson RN. Medication administration considerations for patients receiving enteral tube feeding. Hosp Pharm 2004;39(1):84-9, 96.
5. Gora ML, et al. Considerations of drug therapy in patients receiving enteral nutrition. Nutr Clin Pract 1989; 4(3):105-110
6. Rollins C, et al. Pharmacotherapeutic issues. In: Rolandelli R, et al., editors. Clinical nutrition: enteral and tube feeding. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 291-305.
7. White R, Bradnam V. Handbook of drug administration via enteral feeding tubes. London: Pharmaceutical Press; 2007.
8. Bankhead R, et al. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr 2009;33(2):122-167
9. Belknap DC, et al. Administration of medications through enteral feeding catheters. Am J Crit Care 1997;6(5):382-392
10. Boullata JI, et al. Drug administration by feeding tube: results of a practice-based survey [abstract]. Nutr Clin Pract 2007; 22:126.
11. Leff RD, Roberts RJ. Enteral drug administration practices: report of a preliminary survey. Pediatrics 1988;81(4):549-551
12. Mateo MA. Nursing management of enteral tube feedings. Heart Lung 1996;25(4):318-323
13. Schmieding NJ, Waldman RC. Nasogastric tube feeding and medication administration: a survey of nursing practices. Gastroenterol Nurs 1997;20(4):118-124
14. Seifert CF, Johnston BA. A nationwide survey of long-term care facilities to determine the characteristics of medication administration through enteral feeding catheters. Nutr Clin Pract 2005;20(3):354-362
15. Seifert CF, et al. Drug administration through enteral feeding catheters. Am J Health Syst Pharm 2002;59(4):378-379
16. Horter D, Dressman JB. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 2001;46(1-3):75-87. (Pubitemid 33653415)
17. Dressman JB, et al. Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev 2007;59(7):591-602.
18. Franceschinis E, et al. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm 2005;291(1-2):87-97.
19. Moghimi SM, et al. Nanomedicine: current status and future prospects. FASEB J 2005;19(3):311-330
20. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 2004;61(19-20): 2549-2559
21. Vasiljevic D, et al. An investigation into the characteristics and drug release properties of multiple W/O/W emulsion systems containing low concentration of lipophilic polymeric emulsifier. Int J Pharm 2006;309(1-2):171-177
22. Allan EL, Barker KN. Fundamentals of medication error research. Am J Hosp Pharm 1990;47(3):555-571
23. Curtis JR, et al. Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med 2006;34(1):211-218
24. McCauley K, Irwin RS. Changing the work environment in intensive care units to achieve patient-focused care: the time has come. Am J Crit Care 2006;15(6):541-548
25. Udeani GO, et al. Compatibility of oral morphine sulfate solution with enteral feeding products. Ann Pharmacother 1994;28(4):451-455
26. Burns PE, et al. Physical compatibility of enteral formulas with various common medications. J Am Diet Assoc 1988; 88(9):1094-1096
27. Crowther RS, et al. In vitro stability of ranitidine hydrochloride in enteral nutrient formulas. Ann Pharmacother 1995; 29(9):859-862
28. Cutie AJ, et al. Compatibility of enteral products with commonly employed drug additives. JPEN J Parenter Enteral Nutr 1983;7(2):186-191
29. Holtz L, et al. Compatibility of medications with enteral feedings. JPEN J Parenter Enteral Nutr 1987;11(2):183-186
30. Strom JG, Jr., Miller SW. Stability of drugs with enteral nutrient formulas. DICP 1990;24(2):130-134
31. Lutomski DM, et al. Warfarin absorption after massive small bowel resection. Am J Gastroenterol 1985;80(2):99-102.
32. Mitchell JF, et al. Successful oral anticoagulant therapy in a patient with short bowel syndrome. Am J Hosp Pharm 1977;34(2):171-172
33. Amidon GL, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12(3):413-420
34. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22(1):11-23.
35. Takagi T, et al. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.Mol Pharm 2006;3(6):631-643
36. Freed AL, et al. The development and stability assessment of extemporaneous pediatric formulations of Accupril. Int J Pharm 2005;304(1-2):135-144
37. Park MJ, et al. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion. Biopharm Drug Dispos 2007;28(4):199-207.
38. Schier JG, et al. Fatality from administration of labetalol and crushed extended-release nifedipine. Ann Pharmacother 2003; 37(10):1420-1423
39. Madigan SM, et al. The solution was the problem. Clin Nutr 2002;21(6):531-532
40. Benotti MJ, et al. Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 2009;43(3):597-603.
41. Guenter P, et al. Enteral feeding misconnections: a consortium position statement. Jt Comm J Qual Patient Saf 2008; 34(5):285-92, 45.
42. Clark-Schmidt AL, et al. Loss of carbamazepine suspension through nasogastric feeding tubes. Am J Hosp Pharm 1990; 47(9):2034-2037
43. Seifert CF, et al. Phenytoin recovery from percutaneous endoscopic gastrostomy Pezzer catheters after long-term in vitro administration. JPEN J Parenter Enteral Nutr 1993; 17(4):370-374
44. Trissel LA, American Pharmacists Association. Trissel's stability of compounded formulations. 4th ed. Washington, DC: American Pharmacists Association; 2009.
45. Bansal SS, et al. Molecular and thermodynamic aspects of solubility advantage from solid dispersions. Mol Pharm 2007;4(5):794-802.
46. Scanlan M, Frisch S. Nasoduodenal feeding tubes: prevention of occlusion. J Neurosci Nurs 1992;24(5):256-259
47. Seburg RA, et al. Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation. J Pharm Biomed Anal 2006;42(4):411-422
48. Au Yeung SC, Ensom MH. Phenytoin and enteral feedings: does evidence support an interaction? Ann Pharmacother 2000;34(7-8):896-905.
49. van den Bemt PM, et al. Quality improvement of oral medication administration in patients with enteral feeding tubes. Qual Saf Health Care 2006;15(1):44-47
50. Dansereau RJ, Crail DJ. Extemporaneous procedures for dissolving risedronate tablets for oral administration and for feeding tubes. Ann Pharmacother 2005;39(1):63-67